Latest Glioma Stories

Cell Phones and Brain Cancer: American Academy of Pediatrics Endorses Cell Phone Right to Know Act, Bernstein Liebhard LLP Reports

2012-12-17 05:01:33

The firm continues to investigate potential cell phone radiation lawsuits on behalf of people who developed cancerous brain tumors possibly associated with their use of mobile phones. New York, NY (PRWEB) December 16, 2012 Amid growing concerns of a possible connection between cell phones and brain cancer, the American Academy of Pediatrics (AAP) has endorsed The Cell Phone Right to Know Act, H.R. 6358, Bernstein Liebhard LLP reports. The Act, which is sponsored by Rep Dennis J. Kucinich...

Cell Phone Radiation Lawsuit Update: ICEMS Position Paper Supports Italian Supreme Court Ruling on Cell Phones and Brain Tumors, Bernstein Liebhard LLP Reports

2012-12-10 05:00:16

Bernstein Liebhard LLP continues to investigate potential cell phone radiation lawsuits on behalf of people who developed brain cancer and other tumors possibly associated with their use of mobile phones. New York, New York (PRWEB) December 09, 2012 As cell phone radiation lawsuits continue to move forward in the U.S., the International Commission for Electromagnetic Safety (ICEMS) has released a position paper voicing support for the recent ruling by the Italian Supreme Court that cell...

Reduce Cell Phone Radiation by 97.4% with New Cellsafe Radi-Cushion

2012-12-05 12:26:27

PLANO, Texas, Dec. 5, 2012 /PRNewswire/ -- Evidence continues to grow linking health concerns with cell phone radiation, including brain tumors, pregnancy and fetal development, male infertility, insomnia, memory loss, and migraines amongst the more concerning health issues. The International Agency for Research on Cancer (IARC) has categorised radiation from cell phones as "possibly carcinogenic to humans (Group 2B) based on an increased risk for glioma, a malignant type of...

Brain Tumor Cells Successfully Destroyed

2012-12-04 13:01:02

Use unique combination of diet and radiation therapy A team of brain cancer researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has effectively treated brain tumor cells using a unique combination of diet and radiation therapy. The study, "The Ketogenic Diet Is an Effective Adjuvant to Radiation Therapy for the Treatment of Malignant Glioma," was published in PLOS ONE. Led by Adrienne C. Scheck, PhD, Principal Investigator in Neuro-Oncology and...

Swedish Receives $2.5 Million Grant from the Ivy Foundation to Advance Brain Cancer Research

2012-11-29 08:29:49

The Ivy Center for Advanced Brain Tumor Treatment at Swedish discovers that an FDA-approved treatment for alcoholism may also work for brain cancer New funds from the Ivy Foundation will further this research SEATTLE, Nov. 29, 2012 /PRNewswire-USNewswire/ -- Swedish Medical Center announced today that the Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment (Ivy Center) will receive an additional $2.5 million grant from the Ben & Catherine Ivy Foundation (Ivy...

DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting

2012-11-15 12:27:35

VANCOUVER, British Columbia, Nov. 15, 2012 /PRNewswire/ -- Del Mar Pharmaceuticals (BC) Ltd. ("DelMar Pharma") today announced that the Company will present two scientific posters at the Society for Neuro-Oncology (SNO) 17(th) Annual Scientific Meeting, which is being held in Washington, DC November 15-18, 2012. On Friday November 16(th), DelMar will present a poster entitled, "VAL-083, Novel N7 Alkylating Agent, Surpasses Temozolomide Activity and Inhibits Cancer Stem Cells...

immatics' Renal Cancer Vaccine IMA901 Completes Phase 3 Patient Recruitment and is Granted US Orphan Drug Designation by the FDA

2012-11-08 04:22:53

TUEBINGEN, Germany, November 8, 2012 /PRNewswire/ -- immatics biotechnologies GmbH, a biopharmaceutical company developing rationally designed therapeutic vaccines that are active against cancer, announced today that it has completed patient recruitment into the pivotal phase 3 trial evaluating its lead cancer vaccine IMA901 for renal cell carcinoma (RCC). The trial has completed patient inclusion and it is expected that around 345 patients will be randomized across 10...

Apogenix's Apocept(TM) for Glioblastoma Multiforme Named One of "Top 10 Projects to Watch"

2012-11-06 04:20:49

HEIDELBERG, Germany, Nov. 6, 2012 /PRNewswire/ -- Apogenix, a clinical stage biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases, today announced that its lead product, Apocept(TM) (APG101), has been selected by Elsevier Business Intelligence and Windhover Conferences as one of oncology's "Top 10 Projects To Watch." This announcement is in conjunction with the "Therapeutic Area Partnerships" conference event taking...

New Discovery May Help Doctors Slow Progression And Recurrence Of Brain Cancer

2012-10-22 20:57:41

Scientists have long believed that glioblastoma multiforme (GBM), the most aggressive type of primary brain tumor, begins in glial cells that make up supportive tissue in the brain or in neural stem cells. In a paper published October 18 in Science Express, however, researchers at the Salk Institute for Biological Studies have found that the tumors can originate from other types of differentiated cells in the nervous system, including cortical neurons. GBM is one of the most devastating...

CNS honored guest lecturer Dr. Ralph Dacey speaks on impact of iMRI on Oct. 10

2012-10-10 15:23:41

Describes how VISIUS(®) Surgical Theatre adds value in brain tumor management WINNIPEG, Oct. 10, 2012 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) ("IMRIS" or the "Company") is announcing that the effective impact of high field strength intraoperative MRI (iMRI) for brain tumor management was the focus of the Congress of Neurological Surgeons (CNS) honored guest lecture. Dr. Ralph G. Dacey Jr., the current Henry G. and Edith R. Schwartz professor and chairman of the...